[HTML][HTML] Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis
D Li, EK Schneider-Futschik - Antibiotics, 2023 - mdpi.com
Characterized by impaired mucus transport and subsequent enhanced colonization of
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis
D Li, EK Schneider-Futschik - Antibiotics, 2023 - search.proquest.com
Characterized by impaired mucus transport and subsequent enhanced colonization of
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis
D Li, EK Schneider-Futschik - Antibiotics (Basel …, 2023 - pubmed.ncbi.nlm.nih.gov
Characterized by impaired mucus transport and subsequent enhanced colonization of
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis.
D Li, EK Schneider-Futschik - Antibiotics (Basel, Switzerland), 2023 - europepmc.org
Characterized by impaired mucus transport and subsequent enhanced colonization of
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
[HTML][HTML] Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis
D Li, EK Schneider-Futschik - Antibiotics, 2023 - ncbi.nlm.nih.gov
Characterized by impaired mucus transport and subsequent enhanced colonization of
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
Current and emerging inhaled antibiotics for chronic pulmonary Pseudomonas aeruginosa and Staphylococcus aureus infections in cystic fibrosis.
D Li, EK Schneider-Futschik - 2023 - cabidigitallibrary.org
Characterized by impaired mucus transport and subsequent enhanced colonization of
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis.
D Li, EK Schneider-Futschik - Antibiotics (2079-6382), 2023 - search.ebscohost.com
Characterized by impaired mucus transport and subsequent enhanced colonization of
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …